In addition, the anti-inflammatory properties of Au compounds, which are used for the treatment of inflammatory disorders (such as rheumatoid arthritis, stroke, and cerebral damage), were found to be mediated by inhibiting the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) [74,75,76]. The gene discussed is NFKB1; the disease is stroke disorder.